Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
SomaLogic, Inc. - Class A Common Stock
(NQ:
SLGC
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about SomaLogic, Inc. - Class A Common Stock
< Previous
1
2
Next >
Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting
January 04, 2024
From
Madryn Asset Management, LP
Via
Business Wire
Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools
January 04, 2024
From
Madryn Asset Management, LP
Via
Business Wire
Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools
January 03, 2024
From
Madryn Asset Management, LP
Via
Business Wire
Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures
December 29, 2023
From
Madryn Asset Management, LP
Via
Business Wire
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives
December 26, 2023
From
Madryn Asset Management, LP
Via
Business Wire
Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
December 24, 2023
From
Madryn Asset Management, LP
Via
Business Wire
Madryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
December 22, 2023
From
Madryn Asset Management, LP
Via
Business Wire
ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
December 22, 2023
Company Urges Stockholders to Vote “FOR” Value Maximizing Transaction at Upcoming Special Meeting
From
SomaLogic
Via
GlobeNewswire
Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools
December 22, 2023
From
Madryn Asset Management, LP
Via
Business Wire
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
December 21, 2023
From
SomaLogic
Via
GlobeNewswire
Madryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor Presentation
December 21, 2023
From
Madryn Asset Management, LP
Via
Business Wire
Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioTools
December 20, 2023
From
Skye Fund III, LLC
Via
GlobeNewswire
Madryn Asset Management Issues Presentation Detailing Why SomaLogic Shareholders Should Vote “AGAINST” the Value-Destructive and Deeply Flawed Proposed Merger with Standard BioTools
December 18, 2023
From
Madryn Asset Management, LP
Via
Business Wire
Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
December 17, 2023
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools
December 12, 2023
From
Madryn Asset Management, LP
Via
Business Wire
Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
December 11, 2023
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
December 06, 2023
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
SomaLogic Reports Recent Business Highlights and Third Quarter 2023 Financial Results
November 08, 2023
From
SomaLogic
Via
GlobeNewswire
SomaLogic announces new SomaScan® 11K Platform
November 01, 2023
Expanded menu gives researchers broadest coverage of the proteome for increased discovery of biomarkers and drug targets
From
SomaLogic
Via
GlobeNewswire
SomaLogic to Announce Third Quarter 2023 Financial Results on November 8, 2023
October 31, 2023
From
SomaLogic
Via
GlobeNewswire
SLGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SomaLogic, Inc. Is Fair to Shareholders
October 04, 2023
From
Halper Sadeh LLC
Via
Business Wire
SomaLogic and Korea’s DNA Link partner to bring the 7,000-plex SomaScan® platform to the fast-growing Asia-Pacific proteomics market
September 19, 2023
DNA Link will bring the power of the largest proteomics platform available to their biomarker discovery and drug development work
From
SomaLogic
Via
GlobeNewswire
SomaLogic researchers identify key proteins to aid in early detection of lung, colon and breast cancer and ovarian tumors
September 12, 2023
SomaLogic’s SomaScan® platform was used to target 15 markers shared among all cancer types.
From
SomaLogic
Via
GlobeNewswire
SomaLogic expands agreement with Novo Nordisk to 2025
September 05, 2023
Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases
From
SomaLogic
Via
GlobeNewswire
SomaLogic Reports Second Quarter 2023 Financial Results
August 14, 2023
From
SomaLogic
Via
GlobeNewswire
SomaLogic to Announce Second Quarter 2023 Financial Results on August 14, 2023
July 24, 2023
From
SomaLogic
Via
GlobeNewswire
SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe
July 24, 2023
SomaLogic’s 7,000-plex SomaScan® Platform will be used in proteomics testing at scale in Europe
From
SomaLogic
Via
GlobeNewswire
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe
June 12, 2023
SomaLogic’s 7,000-plex SomaScan® Platform will be used in clinical research, population health studies and nutrigenomics.
From
SomaLogic
Via
GlobeNewswire
SomaLogic Announces Chief Financial Officer Transition
June 06, 2023
From
SomaLogic
Via
GlobeNewswire
SomaLogic to Participate in the Jefferies Healthcare Conference
May 24, 2023
From
SomaLogic
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
